MeSH tree: C04.588.894.797.520.055
Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells become highly resistant to treatment after developing mutations in a key gene called EGFR (epidermal ...
Jan 25, 2026
0
40
A small number of cancer cells with the ability to change their identities and behaviors appear to be a key driver of cancer progression and its ability to evolve resistance to treatment.
Jan 21, 2026
0
29
In Brazil, the early detection of genetic alterations in lung cancer through liquid biopsies could be a valuable tool for expediting diagnoses and guiding patient treatment.
Jan 7, 2026
0
21
Using lung cancer biospecimens from the Sherlock-Lung study, an international team led by National Institutes of Health (NIH) researchers, identified key factors that drive tumor evolution and influence outcomes. Overall, ...
Dec 10, 2025
0
25
Senescent fibroblasts are aging cells that no longer divide and protect against tumor development. Yet two decades have gone by since cell biologist Judith Campisi, Ph.D., paradoxically demonstrated that these same cells ...
Dec 3, 2025
0
11
For some patients with the most common type of lung cancer, known as lung adenocarcinoma, there's new hope. In a new study published in Cell Reports, Mayo Clinic researchers have found several previously unknown genetic and ...
Nov 26, 2025
0
20
NYU Langone Health researchers found that a type of cell death caused by a buildup of highly reactive molecules suppresses lung tumor growth.
Nov 5, 2025
0
50
Lung adenocarcinoma (LUAD) is the most common form of lung cancer, accounting for nearly half of cases. Many patients are diagnosed at advanced stages, and five-year survival remains below 20%.
Oct 22, 2025
0
6
Lung cancer remains one of the deadliest cancers worldwide, with survival rates stubbornly low despite advances in surgery, chemotherapy, and immunotherapy. But a new discovery may change the way doctors approach treatment.
Sep 29, 2025
0
40
About 5% of lung adenocarcinomas, one of the most common forms of lung cancer, are driven by a faulty fusion of two genes, EML4 and ALK. This fusion results in different variants, and until now, clinicians have treated all ...
Sep 23, 2025
0
15
